{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "ee866a4a-1c49-410d-abfe-01e4063751bd",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Libraries\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import matplotlib as mpl\n",
    "import seaborn as sns\n",
    "%matplotlib inline\n",
    "# mpl.rcParams['figure.dpi']= 300\n",
    "sns.set()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "de440911-3f1e-4d62-9627-870cf3550eaf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>category</th>\n",
       "      <th>medicine_name</th>\n",
       "      <th>therapeutic_area</th>\n",
       "      <th>common_name</th>\n",
       "      <th>active_substance</th>\n",
       "      <th>product_number</th>\n",
       "      <th>patient_safety</th>\n",
       "      <th>authorisation_status</th>\n",
       "      <th>atc_code</th>\n",
       "      <th>additional_monitoring</th>\n",
       "      <th>generic</th>\n",
       "      <th>biosimilar</th>\n",
       "      <th>conditional_approval</th>\n",
       "      <th>exceptional_circumstances</th>\n",
       "      <th>accelerated_assessment</th>\n",
       "      <th>orphan_medicine</th>\n",
       "      <th>marketing_authorisation_date</th>\n",
       "      <th>date_of_refusal_of_marketing_authorisation</th>\n",
       "      <th>marketing_authorisation_holder_company_name</th>\n",
       "      <th>pharmacotherapeutic_group</th>\n",
       "      <th>date_of_opinion</th>\n",
       "      <th>decision_date</th>\n",
       "      <th>revision_number</th>\n",
       "      <th>condition_indication</th>\n",
       "      <th>species</th>\n",
       "      <th>first_published</th>\n",
       "      <th>revision_date</th>\n",
       "      <th>url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>human</td>\n",
       "      <td>Adcetris</td>\n",
       "      <td>Lymphoma, Non-Hodgkin;  Hodgkin Disease</td>\n",
       "      <td>brentuximab vedotin</td>\n",
       "      <td>brentuximab vedotin</td>\n",
       "      <td>2455</td>\n",
       "      <td>False</td>\n",
       "      <td>authorised</td>\n",
       "      <td>L01XC12</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>2012-10-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Takeda Pharma A/S</td>\n",
       "      <td>Antineoplastic agents</td>\n",
       "      <td>2012-07-19</td>\n",
       "      <td>2022-11-17</td>\n",
       "      <td>34.0</td>\n",
       "      <td>Hodgkin lymphomaAdcetris is indicated for adul...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018-07-25T13:58:00Z</td>\n",
       "      <td>2023-03-13T11:52:00Z</td>\n",
       "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>human</td>\n",
       "      <td>Nityr</td>\n",
       "      <td>Tyrosinemias</td>\n",
       "      <td>nitisinone</td>\n",
       "      <td>nitisinone</td>\n",
       "      <td>4582</td>\n",
       "      <td>False</td>\n",
       "      <td>authorised</td>\n",
       "      <td>A16AX04</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>2018-07-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cycle Pharmaceuticals (Europe) Ltd</td>\n",
       "      <td>Other alimentary tract and metabolism products,</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>4.0</td>\n",
       "      <td>Treatment of adult and paediatric patients wit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018-07-26T14:20:00Z</td>\n",
       "      <td>2023-03-10T17:29:00Z</td>\n",
       "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>human</td>\n",
       "      <td>Ebvallo</td>\n",
       "      <td>Lymphoproliferative Disorders</td>\n",
       "      <td>tabelecleucel</td>\n",
       "      <td>tabelecleucel</td>\n",
       "      <td>4577</td>\n",
       "      <td>False</td>\n",
       "      <td>authorised</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>2022-12-16</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pierre Fabre Medicament</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-10-13</td>\n",
       "      <td>2023-03-09</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Ebvallo is indicated as monotherapy for treatm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-10-12T16:13:00Z</td>\n",
       "      <td>2023-03-10T13:40:00Z</td>\n",
       "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>human</td>\n",
       "      <td>Ronapreve</td>\n",
       "      <td>COVID-19 virus infection</td>\n",
       "      <td>casirivimab, imdevimab</td>\n",
       "      <td>casirivimab, imdevimab</td>\n",
       "      <td>5814</td>\n",
       "      <td>False</td>\n",
       "      <td>authorised</td>\n",
       "      <td>J06BD</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>2021-11-12</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Roche Registration GmbH</td>\n",
       "      <td>Immune sera and immunoglobulins,</td>\n",
       "      <td>2021-11-11</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>3.0</td>\n",
       "      <td>Ronapreve is indicated for:Treatment of COVID-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-11-12T16:30:00Z</td>\n",
       "      <td>2023-03-10T12:29:00Z</td>\n",
       "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>human</td>\n",
       "      <td>Cosentyx</td>\n",
       "      <td>Arthritis, Psoriatic;  Psoriasis;  Spondylitis...</td>\n",
       "      <td>secukinumab</td>\n",
       "      <td>secukinumab</td>\n",
       "      <td>3729</td>\n",
       "      <td>False</td>\n",
       "      <td>authorised</td>\n",
       "      <td>L04AC10</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>2015-01-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis Europharm Limited</td>\n",
       "      <td>Immunosuppressants</td>\n",
       "      <td>2014-11-20</td>\n",
       "      <td>2023-01-26</td>\n",
       "      <td>30.0</td>\n",
       "      <td>Plaque psoriasisCosentyx is indicated for the ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018-06-07T11:59:00Z</td>\n",
       "      <td>2023-03-09T18:53:00Z</td>\n",
       "      <td>https://www.ema.europa.eu/en/medicines/human/E...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  category medicine_name                                   therapeutic_area  \\\n",
       "0    human      Adcetris            Lymphoma, Non-Hodgkin;  Hodgkin Disease   \n",
       "1    human         Nityr                                       Tyrosinemias   \n",
       "2    human       Ebvallo                      Lymphoproliferative Disorders   \n",
       "3    human     Ronapreve                           COVID-19 virus infection   \n",
       "4    human      Cosentyx  Arthritis, Psoriatic;  Psoriasis;  Spondylitis...   \n",
       "\n",
       "              common_name        active_substance  product_number  \\\n",
       "0     brentuximab vedotin     brentuximab vedotin            2455   \n",
       "1              nitisinone              nitisinone            4582   \n",
       "2           tabelecleucel           tabelecleucel            4577   \n",
       "3  casirivimab, imdevimab  casirivimab, imdevimab            5814   \n",
       "4             secukinumab             secukinumab            3729   \n",
       "\n",
       "   patient_safety authorisation_status atc_code  additional_monitoring  \\\n",
       "0           False           authorised  L01XC12                  False   \n",
       "1           False           authorised  A16AX04                  False   \n",
       "2           False           authorised      NaN                   True   \n",
       "3           False           authorised    J06BD                   True   \n",
       "4           False           authorised  L04AC10                  False   \n",
       "\n",
       "   generic  biosimilar  conditional_approval  exceptional_circumstances  \\\n",
       "0    False       False                 False                      False   \n",
       "1     True       False                 False                      False   \n",
       "2    False       False                 False                       True   \n",
       "3    False       False                 False                      False   \n",
       "4    False       False                 False                      False   \n",
       "\n",
       "   accelerated_assessment  orphan_medicine marketing_authorisation_date  \\\n",
       "0                   False             True                   2012-10-25   \n",
       "1                   False            False                   2018-07-26   \n",
       "2                   False             True                   2022-12-16   \n",
       "3                   False            False                   2021-11-12   \n",
       "4                   False            False                   2015-01-14   \n",
       "\n",
       "  date_of_refusal_of_marketing_authorisation  \\\n",
       "0                                        NaN   \n",
       "1                                        NaN   \n",
       "2                                        NaN   \n",
       "3                                        NaN   \n",
       "4                                        NaN   \n",
       "\n",
       "  marketing_authorisation_holder_company_name  \\\n",
       "0                           Takeda Pharma A/S   \n",
       "1          Cycle Pharmaceuticals (Europe) Ltd   \n",
       "2                     Pierre Fabre Medicament   \n",
       "3                    Roche Registration GmbHÂ    \n",
       "4                  Novartis Europharm Limited   \n",
       "\n",
       "                         pharmacotherapeutic_group date_of_opinion  \\\n",
       "0                            Antineoplastic agents      2012-07-19   \n",
       "1  Other alimentary tract and metabolism products,      2018-05-31   \n",
       "2                                              NaN      2022-10-13   \n",
       "3                 Immune sera and immunoglobulins,      2021-11-11   \n",
       "4                               Immunosuppressants      2014-11-20   \n",
       "\n",
       "  decision_date  revision_number  \\\n",
       "0    2022-11-17             34.0   \n",
       "1    2023-03-10              4.0   \n",
       "2    2023-03-09              2.0   \n",
       "3    2023-02-24              3.0   \n",
       "4    2023-01-26             30.0   \n",
       "\n",
       "                                condition_indication species  \\\n",
       "0  Hodgkin lymphomaAdcetris is indicated for adul...     NaN   \n",
       "1  Treatment of adult and paediatric patients wit...     NaN   \n",
       "2  Ebvallo is indicated as monotherapy for treatm...     NaN   \n",
       "3  Ronapreve is indicated for:Treatment of COVID-...     NaN   \n",
       "4  Plaque psoriasisCosentyx is indicated for the ...     NaN   \n",
       "\n",
       "        first_published         revision_date  \\\n",
       "0  2018-07-25T13:58:00Z  2023-03-13T11:52:00Z   \n",
       "1  2018-07-26T14:20:00Z  2023-03-10T17:29:00Z   \n",
       "2  2022-10-12T16:13:00Z  2023-03-10T13:40:00Z   \n",
       "3  2021-11-12T16:30:00Z  2023-03-10T12:29:00Z   \n",
       "4  2018-06-07T11:59:00Z  2023-03-09T18:53:00Z   \n",
       "\n",
       "                                                 url  \n",
       "0  https://www.ema.europa.eu/en/medicines/human/E...  \n",
       "1  https://www.ema.europa.eu/en/medicines/human/E...  \n",
       "2  https://www.ema.europa.eu/en/medicines/human/E...  \n",
       "3  https://www.ema.europa.eu/en/medicines/human/E...  \n",
       "4  https://www.ema.europa.eu/en/medicines/human/E...  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load data\n",
    "pd.set_option('display.max_columns', None) # display all columns\n",
    "df = pd.read_csv('https://raw.githubusercontent.com/rfordatascience/tidytuesday/master/data/2023/2023-03-14/drugs.csv')\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "9e8c0292-b8c6-4c6d-91ab-59be352b1c54",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "category                                        object\n",
       "medicine_name                                   object\n",
       "therapeutic_area                                object\n",
       "common_name                                     object\n",
       "active_substance                                object\n",
       "product_number                                   int64\n",
       "patient_safety                                    bool\n",
       "authorisation_status                            object\n",
       "atc_code                                        object\n",
       "additional_monitoring                             bool\n",
       "generic                                           bool\n",
       "biosimilar                                        bool\n",
       "conditional_approval                              bool\n",
       "exceptional_circumstances                         bool\n",
       "accelerated_assessment                            bool\n",
       "orphan_medicine                                   bool\n",
       "marketing_authorisation_date                    object\n",
       "date_of_refusal_of_marketing_authorisation      object\n",
       "marketing_authorisation_holder_company_name     object\n",
       "pharmacotherapeutic_group                       object\n",
       "date_of_opinion                                 object\n",
       "decision_date                                   object\n",
       "revision_number                                float64\n",
       "condition_indication                            object\n",
       "species                                         object\n",
       "first_published                                 object\n",
       "revision_date                                   object\n",
       "url                                             object\n",
       "dtype: object"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "54eb950e-0e89-4848-8fa8-bfc92df8d507",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['therapeutic_area',\n",
       " 'common_name',\n",
       " 'active_substance',\n",
       " 'authorisation_status',\n",
       " 'atc_code',\n",
       " 'marketing_authorisation_date',\n",
       " 'date_of_refusal_of_marketing_authorisation',\n",
       " 'marketing_authorisation_holder_company_name',\n",
       " 'pharmacotherapeutic_group',\n",
       " 'date_of_opinion',\n",
       " 'decision_date',\n",
       " 'revision_number',\n",
       " 'condition_indication',\n",
       " 'species',\n",
       " 'revision_date']"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# columns with missing values\n",
    "df.columns[df.isna().any()].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "d6dbe932-84ef-4591-876d-81704ce7beee",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 1988 different drugs with 28 different features (columns) in the dataset.\n"
     ]
    }
   ],
   "source": [
    "print(f\"There are {len(df)} different drugs with {len(df.columns)} different features (columns) in the dataset.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "33015728-3a39-4727-90ef-645c82a280d4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "human         1706\n",
       "veterinary     282\n",
       "Name: category, dtype: int64"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.category.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "6953d306-0941-4fd0-bbf2-8173736cebb0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1976"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.medicine_name.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "d84da38d-35ee-4daa-8dc1-0ab9de7ccead",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "meloxicam                                                                      18\n",
       "adalimumab                                                                     16\n",
       "olanzapine                                                                     12\n",
       "bevacizumab                                                                    12\n",
       "pegfilgrastim                                                                  12\n",
       "                                                                               ..\n",
       "nivolumab, relatlimab                                                           1\n",
       "delamanid                                                                       1\n",
       "roxadustat                                                                      1\n",
       "anifrolumab                                                                     1\n",
       "diphtheria toxoid, hepatitis b, recombinant surface antigen, tetanus toxoid     1\n",
       "Name: active_substance, Length: 1345, dtype: int64"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.active_substance.value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "94365ddc-027f-4d5d-8583-2c6b05029abf",
   "metadata": {},
   "source": [
    "We have to split the lists of string!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ad379e8a-144a-4364-a810-7dfd2aeafa0b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1977\n",
       "True       11\n",
       "Name: patient_safety, dtype: int64"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.patient_safety.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "788eb8b0-31a6-4c23-a8e9-ab6ee1ece20e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "authorised    1573\n",
       "withdrawn      357\n",
       "refused         57\n",
       "Name: authorisation_status, dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.authorisation_status.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "642518c9-d545-4381-a52c-6f89aed7bbee",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1601\n",
       "True      387\n",
       "Name: additional_monitoring, dtype: int64"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.additional_monitoring.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "829c5978-ba98-4e37-b5b2-9b9d9c07576b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1673\n",
       "True      315\n",
       "Name: generic, dtype: int64"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.generic.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "1f44bcb7-70ba-4712-b3c1-ce8dd4815d29",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1896\n",
       "True       92\n",
       "Name: biosimilar, dtype: int64"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.biosimilar.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "d49ba146-7cc8-4dbc-abe8-73196fada2b6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1940\n",
       "True       48\n",
       "Name: conditional_approval, dtype: int64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.conditional_approval.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "a9073115-6768-4c31-9524-cc0995983947",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1940\n",
       "True       48\n",
       "Name: exceptional_circumstances, dtype: int64"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.exceptional_circumstances.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "19692666-a2fa-4be0-bf0f-412b1b202990",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1940\n",
       "True       48\n",
       "Name: accelerated_assessment, dtype: int64"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.accelerated_assessment.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "71f29b9e-1a97-49ea-9b31-9f45625d7397",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False    1826\n",
       "True      162\n",
       "Name: orphan_medicine, dtype: int64"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.orphan_medicine.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "37d6189a-034c-4352-979b-0afb142177ca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(15,5))\n",
    "df.revision_number.value_counts().sort_index().plot.bar()\n",
    "plt.xlabel('revision_number')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eed3125b-b5a8-49cf-9bee-daf5c36ab4c4",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
